Ticker Details
Organon & Co..
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - General
Market Cap:	$3.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 1.83%
Avg Daily Range (30 D):	$0.03 | 0.22%
Avg Daily Range (90 D):	$0.15 | 1.84%

Institutional Daily Volume
Avg Daily Volume:	2.79M
Avg Daily Volume (30 D):	1.93M
Avg Daily Volume (90 D):	5.99M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	133
Avg Trade Size (Sh.) (90 D):	210

Institutional Trades
Total Institutional Trades:	4,703
Avg Institutional Trade:	$3.4M
Avg Institutional Trade (30 D):	$3.45M
Avg Institutional Trade (90 D):	$2.67M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.75M
Avg Closing Trade (30 D):	$7.62M
Avg Closing Trade (90 D):	$6.82M
Avg Closing Volume:	438.62K

News

Jun 22, 2026 @ 5:47 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 17, 2026 @ 1:14 AM Halper Sadeh LLC is Investigating Whether LPRO, NU... Source: Halper Sadeh Llc

Jun 16, 2026 @ 7:56 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 10, 2026 @ 12:04 AM Halper Sadeh LLC is Investigating Whether NUVL, SU... Source: Halper Sadeh Llc

May 22, 2026 @ 6:20 AM Hanmi Pharmaceutical se asocia con Organon para ex... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.94	$.56	$-.79
Diluted EPS	$.94	$.55	$-.78
Revenue	$6.16B	$1.46B	$1.51B
Gross Profit	$3.26B	$783M	$741M
Net Income / Loss	$246M	$146M	$-205M
Operating Income / Loss	$537M	$213M	$-148M
Cost of Revenue	$2.91B	$677M	$766M
Net Cash Flow	$569M	$542M	$-98M
PE Ratio